Synovial tissue hypoxia and inflammation in vivo

Annals of the Rheumatic Diseases

Volumn 69, Issue 7, 2010, Pages 1389-1395

  Ng, C T ^a   Biniecka, M ^a   Kennedy, A ^a   McCormick, J ^a   FitzGerald, O ^a   Bresnihan, B ^a   Buggy, D ^b   Taylor, C T ^c   O'Sullivan, J ^a   Fearon, U ^a   Veale, Douglas J ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; KI 67 ANTIGEN; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; TUMOR NECROSIS FACTOR ALPHA; CHEMOKINE; CYTOKINE; OXYGEN;

ADULT; AGED; APOPTOSIS; ARTHRITIS; ARTHROSCOPY; ARTICLE; BLOOD EXAMINATION; CD3+ T LYMPHOCYTE; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPOXEMIA; IMMUNOHISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; MALE; NICK END LABELING; OXYGEN TENSION; PRIORITY JOURNAL; SYNOVIAL FLUID; SYNOVIAL TISSUE HYPOXIA; SYNOVIOCYTE; SYNOVITIS; SYNOVIUM; BLOOD; CELL HYPOXIA; CELL LINE; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PRESSURE; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; CELL HYPOXIA; CELL LINE; CHEMOKINES; CYTOKINES; HUMANS; MIDDLE AGED; OXYGEN; PARTIAL PRESSURE; SYNOVIAL MEMBRANE; SYNOVITIS;

EID: 77955003794     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2009.119776     Document Type: Article

References (51)

1. Alarcón GS. Epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am 1995;21:589-604.
2. O'Neill T, Silman AJ. Psoriatic arthritis. Historical background and epidemiology. Baillieres Clin Rheumatol 1994;8:245-61.
3. Harris ED Jr. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 1990;322:1277-89.
4. Månsson B, Carey D, Alini M, et al. Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism. J Clin Invest 1995;95:1071-7.
5. Kruithof E, Baeten D, De Rycke L, et al. Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis. Arthritis Res Ther 2005;7:R569-80.
6. Reece RJ, Canete JD, Parsons WJ, et al. Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis. Arthritis Rheum 1999;42:1481-4.
7. Cañete JD, Pablos JL, Sanmartí R, et al. Antiangiogenic effects of anti-tumor necrosis factor alpha therapy with infliximab in psoriatic arthritis. Arthritis Rheum 2004;50:1636-41. (Pubitemid 38608086)
8. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003;423:356-61.
9. Kraan MC, Haringman JJ, Post WJ, et al. Immunohistological analysis of synovial tissue for differential diagnosis in early arthritis. Rheumatology (Oxford) 1999;38:1074-80.
10. Müller-Ladner U, Gay RE, Gay S. Activation of synoviocytes. Curr Opin Rheumatol 2000;12:186-94.
11. McGettrick HM, Smith E, Filer A, et al. Fibroblasts from different sites may promote or inhibit recruitment of flowing lymphocytes by endothelial cells. Eur J Immunol 2009;39:113-25.
12. Raza K, Scheel-Toellner D, Lee CY, et al. Synovial fluid leukocyte apoptosis is inhibited in patients with very early rheumatoid arthritis. Arthritis Res Ther 2006;8:R120.
13. Seemayer CA, Kuchen S, Kuenzler P, et al. Cartilage destruction mediated by synovial fibroblasts does not depend on proliferation in rheumatoid arthritis. Am J Pathol 2003;162:1549-57. (Pubitemid 36512838)
14. Kammouni W, Wong K, Ma G, et al. Regulation of apoptosis in fibroblast-like synoviocytes by the hypoxia-induced Bcl-2 family member Bcl-2/adenovirus E1B 19-kd protein-interacting protein 3. Arthritis Rheum 2007;56:2854-63. (Pubitemid 47502731)
15. Bodamyali T, Stevens CR, Billingham ME, et al. Influence of hypoxia in inflammatory synovitis. Ann Rheum Dis 1998;57:703-10.
16. Stevens CR, Blake DR, Merry P, et al. A comparative study by morphometry of the microvasculature in normal and rheumatoid synovium. Arthritis Rheum 1991;34:1508-13.
17. Lund-Olesen K. Oxygen tension in synovial fluids. Arthritis Rheum 1970;13:769-76.
18. Treuhaft PS, MCCarty DJ. Synovial fluid pH, lactate, oxygen and carbon dioxide partial pressure in various joint diseases. Arthritis Rheum 1971;14:475-84.
19. Etherington PJ, Winlove P, Taylor P, et al. VEGF release is associated with reduced oxygen tensions in experimental inflammatory arthritis. Clin Exp Rheumatol 2002;20:799-805. (Pubitemid 35446970)
20. Peters CL, Morris CJ, Mapp PI, et al. The transcription factors hypoxia-inducible factor 1alpha and Ets-1 colocalize in the hypoxic synovium of inflamed joints in adjuvant-induced arthritis. Arthritis Rheum 2004;50:291-6.
21. Sivakumar B, Akhavani MA, Winlove CP, et al. Synovial hypoxia as a cause of tendon rupture in rheumatoid arthritis. J Hand Surg Am 2008;33:49-58. (Pubitemid 351193088)
22. Hollander AP, Corke KP, Freemont AJ, et al. Expression of hypoxia-inducible factor 1alpha by macrophages in the rheumatoid synovium: implications for targeting of therapeutic genes to the inflamed joint. Arthritis Rheum 2001;44:1540-4.
23. Hitchon C, Wong K, Ma G, et al. Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts. Arthritis Rheum 2002;46:2587-97. (Pubitemid 36118921)
24. Jeon CH, Ahn JK, Chai JY, et al. Hypoxia appears at pre-arthritic stage and shows co-localization with early synovial inflammation in collagen induced arthritis. Clin Exp Rheumatol 2008;26:646-8.
25. Diez H, Fischer A, Winkler A, et al. Hypoxia-mediated activation of Dll4-Notch-Hey2 signaling in endothelial progenitor cells and adoption of arterial cell fate. Exp Cell Res 2007;313:1-9. (Pubitemid 44958449)
26. Biniecka M, Kennedy A, Fearon U, et al. Oxidative damage in synovial tissue is associated with in vivo hypoxic status in the arthritic joint. Ann Rheum Dis. Published Online First: 24 August 2009. doi:10.1136/ard.2009.111211
27. Kennedy A, Ng CT, Biniecka M, et al. Angiogenesis and Blood vessel stability in Inflammatory Arthritis. Arthritis Rhem 2010;62:711-21.
28. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
29. Taylor W, Gladman D, Helliwell P, et al.; CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54:2665-73.
30. Veale DJ. The role of arthroscopy in early arthritis. Clin Exp Rheumatol 1999;17:37-8.
31. Youssef PP, Kraan M, Breedveld F, et al. Quantitative microscopic analysis of inflammation in rheumatoid arthritis synovial membrane samples selected at arthroscopy compared with samples obtained blindly by needle biopsy. Arthritis Rheum 1998;41:663-9. (Pubitemid 28214984)
32. Dingle JT, Thomas DP. In vitro studies on human synovial membrane; a metabolic comparison of normal and rheumatoid tissue. Br J Exp Pathol 1956;37:318-23.
33. Naughton D, Whelan M, Smith EC, et al. An investigation of the abnormal metabolic status of synovial fluid from patients with rheumatoid arthritis by high field proton nuclear magnetic resonance spectroscopy. FEBS Lett 1993;317:135-8. (Pubitemid 23043956)
34. Bresnihan B, Gerlag DM, Rooney T, et al. Synovial macrophages as a biomarker of response to therapeutic intervention in rheumatoid arthritis: standardization and consistency across centers. J Rheumatol 2007;34:620-2. (Pubitemid 46364021)
35. van Kuijk AW, Gerlag DM, Vos K, et al. A prospective, randomised, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: effects of adalimumab treatment on synovial tissue. Ann Rheum Dis 2009;68:1303-9.
36. Bresnihan B, Pontifex E, Thurlings RM, et al. Synovial tissue sublining CD68 expression is a biomarker of therapeutic response in rheumatoid arthritis clinical trials: consistency across centers. J Rheumatol 2009;36:1800-2.
37. Berse B, Hunt JA, Diegel RJ, et al. Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts. Clin Exp Immunol 1999;115:176-82. (Pubitemid 29030382)
38. Westra J, Brouwer E, Bos R, et al. Regulation of cytokine-induced HIF-1alpha expression in rheumatoid synovial fibroblasts. Ann NY Acad Sci 2007;1108:340-8. (Pubitemid 47528746)
39. Bosco MC, Delfino S, Ferlito F, et al. Hypoxic synovial environment and expression of macrophage inflammatory protein 3gamma/CCL20 in juvenile idiopathic arthritis. Arthritis Rheum 2008;58:1833-8. (Pubitemid 351847538)
40. Han MK, Kim JS, Park BH, et al. NF-kappaB-dependent lymphocyte hyperadhesiveness to synovial fibroblasts by hypoxia and reoxygenation: potential role in rheumatoid arthritis. J Leukoc Biol 2003;73:525-9.
41. Makino Y, Nakamura H, Ikeda E, et al. Hypoxia-inducible factor regulates survival of antigen receptor-driven T cells. J Immunol 2003;171:6534-40. (Pubitemid 37532083)
42. Fraser A, Fearon U, Reece R, et al. Matrix metalloproteinase 9, apoptosis, and vascular morphology in early arthritis. Arthritis Rheum 2001;44:2024-8. (Pubitemid 33644044)
43. Tak PP, Klapwijk MS, Broersen SF, et al. Apoptosis and p53 expression in rat adjuvant arthritis. Arthritis Res 2000;2:229-35.
44. Huber LC, Distler O, Tarner I, et al. Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology (Oxford) 2006;45:669-75. (Pubitemid 43985334)
45. Baier A, Meineckel I, Gay S, et al. Apoptosis in rheumatoid arthritis. Curr opin Rheumatol 2003;15:274-9.
46. Cross A, Barnes T, Bucknall RC, et al. Neutrophil apoptosis in rheumatoid arthritis is regulated by local oxygen tensions within joints. J Leukoc Biol 2006;80:521-8. (Pubitemid 44835785)
47. Wijbrandts CA, Remans PH, Klarenbeek PL, et al. Analysis of apoptosis in peripheral blood and synovial tissue very early after initiation of infliximab treatment in rheumatoid arthritis patients. Arthritis Rheum 2008;58:3330-9.
48. Firestein GS, Echeverri F, Yeo M, et al. Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc Natl Acad Sci USA 1997;94:10895-900. (Pubitemid 27430832)
49. Seemayer CA, Kuchen S, Neidhart M, et al. p53 in rheumatoid arthritis synovial fibroblasts at sites of invasion. Ann Rheum Dis 2003;62:1139-44. (Pubitemid 37500618)
50. Merry P, Williams R, Cox N, et al. Comparative study of intra-articular pressure dynamics in joints with acute traumatic and chronic inflammatory effusions: potential implications for hypoxic-reperfusion injury. Ann Rheum Dis 1991;50:917-20.
51. Geborek P, Forslind K, Wollheim FA. Direct assessment of synovial blood flow and its relation to induced hydrostatic pressure changes. Ann Rheum Dis 1989;48:281-6. (Pubitemid 19107330)